U.S. FDA Grants Market Clearance for PyrAmes’ Groundbreaking Boppli® Wearable Blood Pressure Monitor
PyrAmes Inc., a digital health company pioneering innovative blood pressure (BP) monitoring solutions, has received FDA 510(k) clearance for its revolutionary Boppli® platform to safely and accurately monitor the blood pressure of critically-ill infants.